ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Tempest Therpeutics Inc

Tempest Therpeutics Inc (TPST)

0.9701
0.0035
(0.36%)
Cerrado 14 Noviembre 3:00PM
0.92
-0.0501
( -5.16% )
Pre Mercado: 3:06AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.92
Postura de Compra
0.923
Postura de Venta
0.96
Volume Operado de la Acción
3,450
0.00 Rango del Día 0.00
0.8637 Rango de 52 semanas 6.00
Capitalización de Mercado [m]
Precio Anterior
0.9701
Precio de Apertura
-
Última hora de negociación
03:08:40
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
3,225,222
Acciones en circulación
25,207,792
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.83
Beneficio por acción (BPA)
-1.17
turnover
-
Beneficio neto
-29.49M

Acerca de Tempest Therpeutics Inc

Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Tempest Therpeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TPST. The last closing price for Tempest Therpeutics was US$0.97. Over the last year, Tempest Therpeutics shares have traded in a share price range of US$ 0.8637 to US$ 6.00.

Tempest Therpeutics currently has 25,207,792 shares in issue. The market capitalisation of Tempest Therpeutics is US$24.45 million. Tempest Therpeutics has a price to earnings ratio (PE ratio) of -0.83.

TPST Últimas noticias

Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update

Building upon a successful end-of-Phase 2 meeting, received FDA “Study May Proceed” letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCCAnnounced...

Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma

BRISBANE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...

Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial

BRISBANE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...

Tempest Extends Limited Duration Stockholder Rights Plan

BRISBANE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest” or the “Company”), a clinical-stage biotechnology company developing first-in-classi...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.14-13.20754716981.061.160.9225119831.04268116CS
4-0.21-18.58407079651.131.210.863731971601.04135621CS
12-0.57-38.2550335571.491.590.863732252221.10335733CS
26-2.49-73.02052785923.413.64990.863729316261.39914884CS
52-2.24-70.88607594943.1660.863719950432.08656267CS
156-10.46-91.915641476311.3811.980.1715988014.3693515CS
260-12.89-93.338160753113.81410.1714648154.89075057CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
GREEGreenidge Generation Holdings Inc
US$ 3.96
(60.32%)
1.11M
MDCXMedicus Pharma Ltd
US$ 4.07
(53.58%)
11.21k
SYTASiyata Mobile Inc
US$ 1.735
(35.55%)
255.73k
IBGInnovation Beverage Group Limited
US$ 1.39
(28.83%)
214.89k
TCTMTCTM Kids IT Education Inc
US$ 0.98
(21.50%)
1.57k
TFFPTFF Pharmaceuticals Inc
US$ 0.498
(-68.88%)
11.93k
TSSITSS Inc
 8.05
(-32.80%)
746
QUBTQuantum Computing Inc
US$ 3.19
(-27.50%)
936.82k
VVPRVivoPower International PLC
US$ 1.05
(-22.22%)
29.53k
IPWiPower Inc
US$ 0.95
(-20.83%)
26
ELABElevai Labs Inc
US$ 0.0264
(0.76%)
2.84M
GREEGreenidge Generation Holdings Inc
US$ 3.96
(60.32%)
1.11M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 16.65
(-5.45%)
956.31k
QUBTQuantum Computing Inc
US$ 3.19
(-27.50%)
936.82k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 5.21
(5.25%)
555.34k

TPST Discussion

Ver más
georgie18 georgie18 3 días hace
TPST...$1.09...🥳...BRISBANE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that the company received a “Study May Proceed” letter from the U.S. Food and Drug Administration (FDA) to evaluate amezalpat (TPST-1120) in combination with atezolizumab and bevacizumab, the current standard of care, versus the standard of care alone in a pivotal randomized Phase 3 trial for the first-line treatment of unresectable or metastatic hepatocellular carcinoma (HCC).

“The clinical and regulatory team at Tempest are thrilled to receive this notice from FDA with respect to the planned pivotal Phase 3 trial to evaluate amezalpat as a potential treatment for first-line liver cancer,” said Sam Whiting M.D., Ph.D., chief medical officer and head of R&D of Tempest. “Previously reported positive Phase 2 data underscore amezalpat’s potential to improve the survival of patients facing this life-threatening disease, and our team is dedicated to advancing the program and bringing amezalpat to patients.”

georgie18

Member Level
Re: None

Friday, November 08, 2024 6:22:34 PM

Post#
664322
of 664538
TPST...$1.09...Chart firming up from the .85 Range Bottom...R/S coming here...🥳
👍️0
aBeezlee aBeezlee 5 días hace
I sold my shares, but kept the calls.
👍️0
georgie18 georgie18 6 días hace
TPST...$1.09...Chart firming up from the .85 Range Bottom...R/S coming here...🥳
👍️0
aBeezlee aBeezlee 1 semana hace
Not a bad recovery. Will see if an ER or business report is released, then decide to sell or not.
👍️0
Monksdream Monksdream 2 semanas hace
TPST , new 52 week low
👍️0
stockyupydowny stockyupydowny 2 semanas hace
Agreed, we will see positive news and a boost in price prior to the split..... the higher the price the lower the split IF its even required. Should they get positive news and more support from ROCHE this can rocket and then cancel split... that's moon time!
👍️ 1
georgie18 georgie18 2 semanas hace
We shall see...🥳
👍️0
aBeezlee aBeezlee 2 semanas hace
1 to 2, or 1 to 15 RS. The split doesn't make sense unless a notable event is coming. Negative sentiment will simply beat it down, and kill existing holders further.

I'm under the impression dilution is coming.
👍️0
georgie18 georgie18 2 semanas hace
Yes I did...will buy back when the dust settles...🥳...made great profit with TPST and if the reverse should happen it should put this stock in the $40...imo...we shall see...
👍 1
rocketeer357 rocketeer357 2 semanas hace
Did you sell on the 14a news?
👍️0
georgie18 georgie18 2 semanas hace
You saw the 14a...🥳
👍️0
The GidDy uP Kid The GidDy uP Kid 2 semanas hace
aDDed after hours sub $1 range...
👍️0
aBeezlee aBeezlee 2 semanas hace
RS was unexpected for something without a delisting notice. Perhaps something planned to prevent a takeover. Hmm...
👍️0
georgie18 georgie18 2 semanas hace
TPST...14A Filing...Approval of a series of alternate amendments to our Restated Certificate of Incorporation to effect, at the option of our Board of Directors, a reverse stock split of our common stock at a ratio in the range of 1-for-2 to 1-for-15, inclusive, with such ratio to be determined by our Board of Directors in its sole discretion (“Reverse Stock Split Proposal” or “Proposal 1”).
What if another matter is properly brought before the Special Meeting?
👍 1
georgie18 georgie18 2 semanas hace
TPST....85...A/H Dip...🥳
👍️0
georgie18 georgie18 2 semanas hace
Nice to have you with me on it...🥳
👍️0
tw0122 tw0122 2 semanas hace
One of your GM favorites been adding myself low $1s for next blastoff to $2s ...newsand trials
👍️0
georgie18 georgie18 2 semanas hace
TPST...$1.16s in the P/M...🥳

georgie18

Member Level
Re: georgie18 post# 614

Friday, October 25, 2024 12:38:28 PM

Post#
615
of 617
TPST...$1.12s clearing here...🥳Reversing...

georgie18

Member Level
Re: georgie18 post# 662364

Friday, October 25, 2024 9:43:40 AM

Post#
662715
of 662771
TPST...$1.08...Big Block Buys hitting here...🥳

georgie18

Member Level
Re: None

Wednesday, October 23, 2024 8:55:30 AM

Post#
613
of 613
TPST...Loaded $1.03 to $1.05s...🥳
👍️0
aBeezlee aBeezlee 3 semanas hace
Long hold. Roche wouldn't supply them with goods if they felt phase 3 would fail. Looking for $2 on positive results.
👍️0
georgie18 georgie18 3 semanas hace
Have a Great Weekend Y'all...🥳
👍️0
georgie18 georgie18 3 semanas hace
TPST...$1.12s clearing here...🥳Reversing...

georgie18

Member Level
Re: georgie18 post# 662364

Friday, October 25, 2024 9:43:40 AM

Post#
662715
of 662771
TPST...$1.08...Big Block Buys hitting here...🥳

georgie18

Member Level
Re: None

Wednesday, October 23, 2024 8:55:30 AM

Post#
613
of 613
TPST...Loaded $1.03 to $1.05s...🥳
👍️0
georgie18 georgie18 3 semanas hace
TPST...$1.08...Big Block Buys hitting here...🥳

georgie18

Member Level
Re: None

Wednesday, October 23, 2024 8:55:30 AM

Post#
613
of 613
TPST...Loaded $1.03 to $1.05s...🥳
👍️0
georgie18 georgie18 3 semanas hace
TPST...Loaded $1.03 to $1.05s...🥳
👍️0
Xunefox Xunefox 4 semanas hace
May be an AH show after all
👍️0
aBeezlee aBeezlee 4 semanas hace
Yup TPST! I have RNAZ on list too. Buying both with next check. 🔥
👍️0
georgie18 georgie18 4 semanas hace
TPST...$1.22...🥳...Dipping it to fill the Open Gap...another great add spot...Ran to $1.60 range in the A/H ...

georgie18

Member Level
Re: georgie18 post# 384329

Tuesday, October 15, 2024 3:37:36 PM

Post#
384411
of 384426
TPST...$1.14clearing here...🥳

georgie18

Member Level
Re: None

Friday, October 11, 2024 9:46:27 AM

Post#
603
of 603
TPST...99...great add spot....🥳
👍️0
georgie18 georgie18 4 semanas hace
TPST …yes beauty move in the A/H…🥳
👍️0
Vitamin310 Vitamin310 4 semanas hace
I’m in!
👍️0
Money hunt Money hunt 4 semanas hace
TPST smell green dude!!! RNAZ Next DRUG
👍️0
The GidDy uP Kid The GidDy uP Kid 1 mes hace
Nice Georgie… TPST $1.61 after hours close…
👍️0
aBeezlee aBeezlee 1 mes hace
The next DRUG?!
👍️0
georgie18 georgie18 1 mes hace
TPST...$1.14clearing here...🥳

georgie18

Member Level
Re: None

Friday, October 11, 2024 9:46:27 AM

Post#
603
of 603
TPST...99...great add spot....🥳
👍️0
georgie18 georgie18 1 mes hace
TPST...99...great add spot....🥳
👍️0
Invest-in-America Invest-in-America 1 mes hace
TPST: Nope!! Cancer is NOT trending anymore, CLOWN!!! (Nice call, IDIOT!!!)
👍️0
georgie18 georgie18 1 mes hace
TPST...$1.09...Great add opportunity...imo...we shall see...🥳
👍️0
georgie18 georgie18 1 mes hace
TPST...$1.59...from the .90 range bottom...🥳BRISBANE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced an agreement with Roche to advance the evaluation of amezalpat (TPST-1120) in combination with atezolizumab (Tecentriq®) and bevacizumab, the current standard of care for unresectable or metastatic hepatocellular carcinoma (HCC), into a pivotal Phase 3 trial for the first-line treatment of unresectable or metastatic hepatocellular carcinoma, a form of liver cancer with high unmet need.

georgie18

Member Level
Re: None

Friday, August 09, 2024 2:43:01 PM

Post#
652989
of 660804
TPST...$1.16...Taking a hit on earnings...adding more down here...🥳
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
july shelf offering allows lender to sell stock at anytime
👍️0
Invest-in-America Invest-in-America 1 mes hace
TPST: Hopefully!! (But is "Cancer" TRENDING anymore??)
👍️0
tw0122 tw0122 1 mes hace
TPST 1.82 +’35% resistance at 1.85 looks good again until 2.01- 2.23 resistance then big jump to 2.91

a pivotal Phase 3 trial for the first-line treatment of unresectable or metastatic hepatocellular carcinoma, a form of liver cancer with high unmet need.
Under the agreement, Roche will supply atezolizumab globally and Tempest will sponsor and lead the pivotal study. This agreement builds on a clinical collaboration between the companies pursuant to which amezalpat was combined with atezolizumab and bevacizumab in first-line HCC patients and compared to atezolizumab and bevacizumab alone in a randomized Phase 1b/2 study. Tempest retains all development and commercial rights to amezalpat.
👍️0
Invest-in-America Invest-in-America 1 mes hace
TPST: I'm in!! Are you?? (Heck, goin' to Phase-3 with Roche?? I'll jump-on for ride!!)

👍️0
Invest-in-America Invest-in-America 1 mes hace
TPST: Some Roche agreement news.
👍️0
georgie18 georgie18 2 meses hace
TPST...$1.44s clearing on the 50MA Break...🥳
👍️0
georgie18 georgie18 2 meses hace
TPST...$1.50s clearing into the close...🥳
👍️0
georgie18 georgie18 2 meses hace
Have a Great Weekend Y'all...🥳
👍️0
georgie18 georgie18 2 meses hace
Nice...will be very pleased with 1/2 that target...🥳
👍️0
glens0 glens0 2 meses hace
Bought a starter today.
DJ Tempest Therapeutics Price Target Maintained With a $47.00/Share by HC Wainwright & Co.
12:54 PM ET 8/15/24 | Dow Jones
👍️0
georgie18 georgie18 2 meses hace
TPST...$1.35...🥳
👍️0
georgie18 georgie18 3 meses hace
TPST...$1.44...HOD...🥳
👍️0
georgie18 georgie18 3 meses hace
TPST...$1.50...Off the .90 range dip...🥳...was $6 recently...setting up for a Breakout...imo...we shall see...
👍️0
georgie18 georgie18 3 meses hace
TPST...1.4995...HOD...Beauty move off the .90 range dip...🥳Was $6 a couple of months ago...🥳
👍️0

Su Consulta Reciente

Delayed Upgrade Clock